Home
Journal Issues
Current Issue
In Press
Archive
Guidelines
About the journal
Author Guidelines
Peer-Review Policy
Open Access and Copyright
Author Agreement Form
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2025, Vol 14, No. 4
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
Review
1. Continuation or termination of metformin in diabetic patients exposed to iodinated contrast medium?
Mohamad Ali Dayani*
J Renal Inj Prev
. 2019;8(3): 185-189.
doi:
10.15171/jrip.2019.34
Scopus ID:
85072559186
Article
PDF
XML
Cited By:
0
0
×
Continuation or termination of metformin in diabetic patients exposed to iodinated contrast medium?
Original
2. Impact of allopurinol on metabolic acidosis in patients with chronic kidney disease; a randomized controlledtrial
Davood Gholami, Maryam Hami
, Boshra Hasanzamani
, Maryam Miri*
J Renal Inj Prev
. 2019;8(3): 216-220.
doi:
10.15171/jrip.2019.40
Scopus ID:
85072552524
Article
PDF
XML
Cited By:
1
0
×
Impact of allopurinol on metabolic acidosis in patients with chronic kidney disease; a randomized controlledtrial
Epidemiology and Prevention
3. Renal manifestations of metformin-associated lactic acidosis; new findings
Parisa Tajdini, Majid Foroutan*
J Renal Inj Prev
. 2024;13(4): e32258.
doi:
10.34172/jrip.2024.32258
Article
PDF
XML
Cited By:
0
×
Renal manifestations of metformin-associated lactic acidosis; new findings
